Quantification of Women Who Could Benefit from Hormone Therapy after Endometrial Cancer Treatment: An Analysis of SEER Data

Our primary aim was to estimate the magnitude of stage I endometrial cancer (EC) survivors that could benefit from hormonal therapy (HT). Our secondary aims were to assess EC incidence in women below 50 and below 60 over the years, and analyze the overall survival and any influencing factors. We ana...

Descripción completa

Detalles Bibliográficos
Autores principales: Londero, Ambrogio P., Xholli, Anjeza, Bertozzi, Serena, Orsaria, Maria, Paudice, Michele, Mariuzzi, Laura, Cagnacci, Angelo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9777495/
https://www.ncbi.nlm.nih.gov/pubmed/36547135
http://dx.doi.org/10.3390/curroncol29120721

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9777495/
https://www.ncbi.nlm.nih.gov/pubmed/36547135
http://dx.doi.org/10.3390/curroncol29120721

Ejemplares similares